US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Renaissance Technologies Holdings

1,867.14

+41.192.26%

Number of Gainers:76

Number of Losers:20

Number of Flat:- -

PE:- -

High:1,869.48

Open:1,832.50

Low:1,832.50

Close:1,825.96

Loading ...

Press Release: Hershey Announces Stacy Taffet as Chief Growth Officer

Eli Lilly-Incyte Partnered FDA-Approved Drug Shows Encouraging Efficacy In Adolescent Patients With Patchy Hair Loss

2 Brilliant Growth Stocks to Buy Now and Hold for the Long Term

IONS/AZN Get FDA Nod for Amyloidosis Drug, Wainzua in Europe

Is Newmont (NEM) the Cheap Gold Stock to Invest in Right Now?

Novo Nordisk's Combo Drug CagriSema Shows 16% Weight Reduction In Second Phase 3 Trial

Have Domino's Pizza Insiders Been Selling Stock?

Simply Wall St.

Dow Jones Leader McDonald's, Kroger Eye Buy Points Despite Stock Market Sell-Off

The Dreaded Trump Bear Market Is Here Now For 40% Of The S&P 500

CrowdStrike Recognizes 2025 Partner Award Winners at Asia Pacific and Japan Partner Symposium

Is Palo Alto Networks (PANW) the Best Cybersecurity Stock to Buy According to Billionaires?

Biogen announces initiation of dosing in TRANSCEND

OS Therapies Schedules United Kingdom’s Medicines and Healthcare products Regulatory Agency's (MHRA) Scientific Advice Meeting in the Third Quarter of 2025 for Review of its OST-HER2 Immunotherapy Candidate for Osteosarcoma

QUALCOMM (QCOM): One of the Best Cheap Dividend Stocks to Buy Right Now

Biogen Initiates Phase 3 Study of Felzartamab for the Treatment of Late Antibody-Mediated Rejection (AMR) in Kidney Transplant Patients

New Strong Buy Stocks for March 11th

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.tigerhkgo.com/stock/BK4532/news?page=19"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK4532"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4532\",,,,,undefined,":{"symbol":"BK4532","market":"US","secType":"PLATE","nameCN":"Renaissance Technologies Holdings","latestPrice":1867.1416,"timestamp":1741982399999,"preClose":1825.9556,"halted":0,"volume":973283508,"delay":0,"changeRate":0.022556,"change":41.186035,"pbRate":8.237634,"amount":110814604672.16774,"amplitude":0.020253,"prevYearClose":2026.1482,"fiveDayClose":1912.7213,"twentyDayClose":2056.6948,"turnoverRate":0.007563,"marketCap":20819946008240,"floatMarketCap":19483724856216,"peRate":30.087245},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4532\",,,,,undefined,":{"symbol":"BK4532","high":1869.4794,"amplitude":0.020253,"preClose":1825.9556,"low":1832.4988,"pbRate":"8.237634","latestPrice":1867.1416,"volume":973283508,"delay":0,"open":1832.4988,"prevYearClose":2026.1482,"prevWeekClose":1912.7213,"prevMonthClose":1965.7411,"prevQuarterClose":2026.1482,"fiveDayClose":1912.7213,"twentyDayClose":2056.6948,"sixtyDayClose":2078.8435,"secType":"PLATE","market":"US","turnoverRate":0.007563,"peRate":30.087245,"marketCap":20819946008240,"floatMarketCap":19483724856216,"timestamp":1741982399999,"nameCN":"Renaissance Technologies Holdings"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4532\",,,,undefined,":{"bkCode":"BK4532","up":76,"down":20,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4532\",pageSize:16,pageCount:19,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2518746986","title":"Press Release: Hershey Announces Stacy Taffet as Chief Growth Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2518746986","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518746986?lang=en_us&edition=fundamental","pubTime":"2025-03-11 20:55","pubTimestamp":1741697700,"startTime":"0","endTime":"0","summary":"HERSHEY, Pa., March 11, 2025 /PRNewswire/ -- The Hershey Company  today announced Stacy Taffet as its Chief Growth Officer, effective April 14, 2025. In this role, she will be responsible for driving transformative growth strategies across the company's expanding snacks portfolio, which includes iconic brands like Hershey's, Reese's, Jolly Rancher and Dot's Homestyle Pretzels.Stacy is a seasoned marketing executive with 20 years of transformative leadership experience, including 15 years in consumer-packaged goods  and a distinguished PepsiCo career spanning multiple brand portfolios--most recently as Senior Vice President of Beverage Portfolio Strategy and Marketing.Throughout her tenure, she has consistently driven significant business growth, leading large teams and managing multi-billion-dollar brands across beverages and snacks, including successful marketing transformations for iconic brands like Pepsi and bubly. Her expertise spans brand management, digital marketing, innovation","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4022","R","BK4504","BK4533","BK4588","BK4212","BK4532","BK4585","HSY","BK4232"],"gpt_icon":0},{"id":"2518674939","title":"Eli Lilly-Incyte Partnered FDA-Approved Drug Shows Encouraging Efficacy In Adolescent Patients With Patchy Hair Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2518674939","media":"Benzinga","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518674939?lang=en_us&edition=fundamental","pubTime":"2025-03-11 20:48","pubTimestamp":1741697328,"startTime":"0","endTime":"0","summary":"On Saturday, Eli Lilly And Co and IncyteCorporation  said adolescent patients with severe alopecia areata  treated with once-daily oral baricitinib 4 mg and 2 mg saw clinically meaningful improvements in hair regrowth on the scalp, eyebrows, and eyelashes at Week 36.Findings from the Phase 3 BRAVE-AA-PEDS study were presented at the American Academy of Dermatology.AA is an immune system condition that causes patchy hair loss on the scalp, face, and sometimes other body areas, which can progress over time.In 2022, the U.S. Food and Drug Administration  approved baricitinib, also known as Olumiant, for adult patients with severe AA.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/eli-lilly-incyte-partnered-fda-124848577.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1267930730.SGD","IE00BK4W5L77.USD","LU1057294990.SGD","LU1093756325.SGD","LU0708995401.HKD","LU1551013342.USD","SG9999014880.SGD","LU0203202063.USD","LU2264538146.SGD","LU1917777945.USD","AA","BK4533","LU0238689110.USD","LU0823416689.USD","LU2237443549.SGD","LU2491049909.HKD","SG9999018857.SGD","LU0354030438.USD","LU1983299246.USD","LU0114720955.EUR","LU1868836757.USD","INCY","LU1280957306.USD","LU2324357040.USD","LU1548497426.USD","LU0106261372.USD","LU1720051017.SGD","LU1804176565.USD","BK4534","LU0203201768.USD","SGXZ57979304.SGD","LU1989771016.USD","LU0471298694.HKD","LU1127390331.HKD","LU1868836591.USD","LU0122379950.USD","LU1551013425.SGD","LU0417517546.SGD","LU2237438978.USD","BK4532","BK4007","LU2361044949.HKD","IE00BFTCPJ56.SGD","LU2361045086.USD","LLY","BK4588","IE0004445239.USD","SG9999001176.SGD","LU1035775433.USD","LU1366192091.USD"],"gpt_icon":1},{"id":"2518464447","title":"2 Brilliant Growth Stocks to Buy Now and Hold for the Long Term","url":"https://stock-news.laohu8.com/highlight/detail?id=2518464447","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518464447?lang=en_us&edition=fundamental","pubTime":"2025-03-11 20:45","pubTimestamp":1741697100,"startTime":"0","endTime":"0","summary":"Artificial intelligence is one of the best investment opportunities in years.One company is a clear leader in custom AI processors.Investors should keep paying attention to the hottest AI stock in the market.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/03/11/brilliant-growth-stocks-to-buy-now-and-hold/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["LU1303367103.USD","HK0000320264.USD","LU2271345857.HKD","NVDS.UK","NVDS","LU1670628061.USD","NVDU","IE00BJTD4V19.USD","LU1267930490.SGD","LU2242649171.HKD","LU2491049909.HKD","LU1032955483.USD","LU0251132253.USD","LU2023250330.USD","IE00BZ1G4Q59.USD","BK4598","LU0444971666.USD","NVDD","IE00BQXX3D17.EUR","LU0965509283.SGD","NVD3.UK","IE00BKPKM429.USD","LU0320765059.SGD","LU1623119135.USD","BK4543","LU0096362180.USD","NVDY","LU0820561818.USD","SNVD.UK","LU0215105999.USD","BK4532","LU2326559502.SGD","LU0683600562.USD","NVIW.SI","LU0080751232.USD","2NVD.UK","BK4585","NVD2.UK","SG9999015986.USD","LU2413666699.HKD","NVDA","LU2213496289.HKD","LU0426417589.USD","3NVD.UK","LU1244550221.USD","LU1852331112.SGD"],"gpt_icon":1},{"id":"2518723100","title":"IONS/AZN Get FDA Nod for Amyloidosis Drug, Wainzua in Europe","url":"https://stock-news.laohu8.com/highlight/detail?id=2518723100","media":"Zacks","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518723100?lang=en_us&edition=fundamental","pubTime":"2025-03-11 20:43","pubTimestamp":1741696980,"startTime":"0","endTime":"0","summary":"Ionis Pharmaceuticals IONS announced that the European Commission  has approved Wainzua  for treating adult patients with hereditary transthyretin-mediated amyloidosis with stage 1 or stage 2 polyneuropathy . The drug has been developed in partnership with AstraZeneca AZN.This approval was expected as the EMA’s Committee for Medicinal Products for Human Use  issued a positive opinion recommending the approval of Wainzua in the above indication in October.The EC and CHMP decisions are based on positive data from the phase III NEURO-TTRansform study, which evaluated the safety and efficacy of Wainzua in patients with ATTRv-PN. Data from this study showed that treatment with the drug led to consistent and sustained benefit in the co-primary endpoints of serum transthyretin  concentration and neuropathy impairment. Treatment with Wainzua also improved quality of life versus placebo, a key secondary endpoint of the NEURO-TTRansform study.ATTRv-PN is a debilitating disease,which leads to per","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ions-azn-fda-nod-amyloidosis-124300822.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IONS","HAE","BK4198","AZN","IE00B19Z9Z06.USD","LU2417539215.USD","GSK","LU2236285917.USD","IE00BLDYK493.USD","LU1829250122.USD","LU2456880835.USD","IE00B894F039.SGD","LU0234570918.USD","IE00B19Z9P08.USD","LU0889565916.HKD","LU0205194284.USD","BK4588","LU0205193047.USD","LU1169589451.USD","LU0012050646.USD","LU0109394709.USD","LU0106261612.USD","BK4585","LU2462157665.USD","BK4568","BK4532","BK4139","BK4533","LU0320765992.SGD","GSK.UK","BK4007","IE00B64QTZ34.USD","CHB","LU1169590202.USD","BIIB"],"gpt_icon":0},{"id":"2518749044","title":"Is Newmont (NEM) the Cheap Gold Stock to Invest in Right Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2518749044","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518749044?lang=en_us&edition=fundamental","pubTime":"2025-03-11 20:42","pubTimestamp":1741696974,"startTime":"0","endTime":"0","summary":"We recently published a list of the 10 Cheap Gold Stocks to Invest In Right Now. In this article, we are going to take a look at where Newmont Corporation  stands against the other cheap gold stocks to invest in right now.The World Gold Council said in its annual report that the global demand for gold hit a record high in 2024, fueled by investment demand growth and robust central bank purchases. Total gold transactions reached 4,974 tons in 2024, up from 4,899 tons in 2023, including over-the-counter  investments. Central banks are exhibiting an “insatiable” appetite for gold. The Council said they have attained a significant milestone, maintaining a continuously solid pace of gold purchases. The buying exceeded 1,000 tons for the third consecutive year in 2024.In contrast to the demand for gold, the jewelry sector","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/newmont-nem-cheap-gold-stock-124254007.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["LU0300736062.USD","LU0368265764.SGD","LU0266512127.USD","LU1883866441.USD","LU0330918003.SGD","BK4017","LU0788109121.HKD","LU0075056555.USD","LU1023059493.AUD","LU0055631609.USD","LU0612318971.USD","LU0724618789.USD","LU0498741114.HKD","LU1280957306.USD","LU0300736492.USD","NEM","LU1223082519.USD","LU0456854461.SGD","NEM.AU","LU0612318385.USD","LU1430597077.USD","LU0788108826.HKD","LU1223082196.USD","LU1223083913.SGD","LU0496367417.USD","BK4533","LU0654597011.USD","BK4532","LU0640476718.USD","BK7104","BK4585","SG9999001143.SGD","BK4570","LU2498475776.HKD","LU2462611646.USD","LU0498741890.SGD","BK4588","LU0278409577.USD","LU0345780521.USD","LU0345780281.USD"],"gpt_icon":0},{"id":"2518450577","title":"Novo Nordisk's Combo Drug CagriSema Shows 16% Weight Reduction In Second Phase 3 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2518450577","media":"Benzinga","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518450577?lang=en_us&edition=fundamental","pubTime":"2025-03-11 20:35","pubTimestamp":1741696546,"startTime":"0","endTime":"0","summary":"On Monday, Novo Nordisk A/S  announced headline results from the REDEFINE 2 phase 3 trial in the global REDEFINE program.REDEFINE 2 is a 68-week efficacy and safety trial investigating once-weekly subcutaneous CagriSema  compared to placebo.The trial included 1,206 randomized people with obesity or overweight, type 2 diabetes, and a mean baseline body weight of 102 kg.The REDEFINE 2 trial was based on a flexible protocol, allowing patients to modify their dosing throughout the trial.Also Read: Weight Loss Drugs Soar While Global Obesity Rates Climb, To Hit 50% Of Adults By 2050 Says New Report. After 68 weeks, 61.9% of patients treated with CagriSema were on the highest dose.When evaluating treatment effects, if all people adhered to treatment, people treated with CagriSema achieved a weight loss of 15.7% after 68 weeks compared to 3.1% with placebo.In December, in the REDEFINE 1 Phase 3 trial, CagriSema achieved a weight loss of 22.7% after 68 weeks compared to a reduction of 11.8% wi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/novo-nordisks-combo-drug-cagrisema-123546227.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Novo Nordisk's Combo Drug CagriSema Shows 16% Weight Reduction In Second Phase 3 Trial","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4532","BK4599","LU0154236417.USD","BK4007","BK4585","BK4588","LU1093756168.USD","LU1093756325.SGD","IE00BZ1G4Q59.USD","NVO","IE00BKVL7J92.USD"],"gpt_icon":1},{"id":"2518972075","title":"Have Domino's Pizza Insiders Been Selling Stock?","url":"https://stock-news.laohu8.com/highlight/detail?id=2518972075","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518972075?lang=en_us&edition=fundamental","pubTime":"2025-03-11 20:25","pubTimestamp":1741695949,"startTime":"0","endTime":"0","summary":"We wouldn't blame Domino's Pizza, Inc. ( NASDAQ:DPZ ) shareholders if they were a little worried about the fact that...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/4214000-choice2-main-header/1585186565403","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/4214000-choice2-main-header/1585186565403"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/consumer-services/nasdaq-dpz/dominos-pizza/news/have-dominos-pizza-insiders-been-selling-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["DPZ","BK4585","BK4588","BK4524","BK4532","BK4209"],"gpt_icon":0},{"id":"2518741998","title":"Dow Jones Leader McDonald's, Kroger Eye Buy Points Despite Stock Market Sell-Off","url":"https://stock-news.laohu8.com/highlight/detail?id=2518741998","media":"Blockhead","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518741998?lang=en_us&edition=fundamental","pubTime":"2025-03-11 20:00","pubTimestamp":1741694425,"startTime":"0","endTime":"0","summary":"Dow Jones leader McDonald's, along with Kroger and Veeva, are in or near buy zones despite Monday's stock market sell-off.","market":"hk","thumbnail":"https://www.investors.com/wp-content/uploads/2022/05/Stock-mcdonalds-goldenarches-01-adobe-150x150.jpg","type":0,"news_type":0,"thumbnails":["https://www.investors.com/wp-content/uploads/2022/05/Stock-mcdonalds-goldenarches-01-adobe-150x150.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.investors.com/stock-lists/stocks-near-a-buy-zone/dow-jones-mcdonalds-stock-mcd-stock-market-sell-off/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"investor_business_daily_highlight","symbols":["LU1917777945.USD","LU2106854487.HKD","LU0477156953.USD","LU0011850046.USD","BK4588","LU0345770993.USD","IE00B7KXQ091.USD","BK4581","LU0980610538.SGD","LU0058720904.USD","GB00BDT5M118.USD","IE00BJJMRY28.SGD","MCD","BK4533","LU1201861249.SGD","BK4122","LU2023250843.SGD","BK4559","BK4532","KR","LU1244550221.USD","BK4209","ICE.AU","LU0648001328.SGD","IE00BJTD4V19.USD","LU0689626769.HKD","IE00BQXX3D17.EUR","LU1718418525.SGD","LU2275660780.HKD","PCOM","BK4113","LU0154245673.USD","BK7016","BK4534","ICE","LU0868494617.USD","BK4528","SGXZ23171101.USD","LU1244550494.USD","LU0266013472.USD","BK4504","LU0949170772.SGD","LU0738911758.USD","LU2133065610.SGD","VEEV","LU0942090050.USD","BK4610","BK4613","LU1989764664.SGD","LU0345770308.USD"],"gpt_icon":0},{"id":"2518743503","title":"The Dreaded Trump Bear Market Is Here Now For 40% Of The S&P 500","url":"https://stock-news.laohu8.com/highlight/detail?id=2518743503","media":"Blockhead","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518743503?lang=en_us&edition=fundamental","pubTime":"2025-03-11 20:00","pubTimestamp":1741694408,"startTime":"0","endTime":"0","summary":"Not sure when President Trump's tariff strategy will push the S&P 500 into a bear market? It's already here for 40% of the S&P 500.","market":"hk","thumbnail":"https://www.investors.com/wp-content/uploads/2022/03/Stock-moneydowndrain-01-adobe-150x150.jpg","type":0,"news_type":0,"thumbnails":["https://www.investors.com/wp-content/uploads/2022/03/Stock-moneydowndrain-01-adobe-150x150.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.investors.com/etfs-and-funds/sectors/sp500-dreaded-trump-bear-market-is-here-now-for-40-stocks/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"investor_business_daily_highlight","symbols":["SDS","LU0198837287.USD","LU0466842654.USD","TSLL","LU2250418816.HKD","LU0077335932.USD","BK4593","LU2360106780.USD","SPXU","SG9999015978.USD","LU1435385759.SGD","LU0345769128.USD","VOO","SPY","IE00BSNM7G36.USD","BK4598","LU1914381329.SGD","LU1066053197.SGD","LU0823411888.USD","BK4612","LU0056508442.USD","SG9999015986.USD","UPRO","LU0097036916.USD",".SPX","BK4534","LU0943347566.SGD","SH","LU0345769631.USD","IVV","OEF","SG9999015952.SGD","LU0348723411.USD","LU2023250330.USD","CE","ESmain","LU2471134523.USD","TSYW.SI","BK4109","BK4532","BK4099","IE00BJLML261.HKD","LU0053666078.USD","SSO","BK4588","OEX"],"gpt_icon":1},{"id":"2518743472","title":"CrowdStrike Recognizes 2025 Partner Award Winners at Asia Pacific and Japan Partner Symposium","url":"https://stock-news.laohu8.com/highlight/detail?id=2518743472","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518743472?lang=en_us&edition=fundamental","pubTime":"2025-03-11 20:00","pubTimestamp":1741694400,"startTime":"0","endTime":"0","summary":"AUSTIN, Texas & TAIPEI, Taiwan, March 11, 2025----APJ Partner Symposium – CrowdStrike  today announced the winners of the annual CrowdStrike Asia Pacific and Japan  Partner Awards at its 2025 APJ Partner Symposium in Taipei. The APJ Partner Symposium unites CrowdStrike’s ecosystem, bringing together leading channel and distributor, service provider and technology alliance partners across the region. The exclusive, invite-only meeting covers content, training and updates to accelerate partners’ growing and scaling their CrowdStrike businesses, helping customers consolidate their security spend and stop breaches with the industry-leading CrowdStrike Falcon cybersecurity platform.CrowdStrike’s APJ Partner Awards recognize the incredible impact and effort that partners throughout the region have accomplished in the previous year. With a partner-first go-to-market strategy, the power of CrowdStrike’s partner ecosystem is critical to transforming cybersecurity for leading organizations in AP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/crowdstrike-recognizes-2025-partner-award-120000499.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4543","LU2125909247.SGD","LU2272731600.USD","BK4588","BK4598","LU2125909593.SGD","LU2023250504.SGD","LU2106854487.HKD","LU1951200564.SGD","LU2272731782.SGD","LU0081259029.USD","LU2125909759.SGD","IE00B894F039.SGD","LU1917777945.USD","LU2357305700.SGD","LU1923623000.USD","BK4097","LU1951198990.SGD","LU2125909916.SGD","CRWD","BK4532","LU2211815571.USD","LU1548497426.USD","LU1720051108.HKD","LU1974910355.USD","LU2264538146.SGD","LU2286300806.USD","IE00B19Z9P08.USD","LU1720051017.SGD","LU1064131342.USD","LU1923622614.USD","LU1923622291.USD","LU1992135399.USD","BK4585","BK4560","IE00BZ9MQY76.HKD","LU1988902786.USD","IE00B19Z9Z06.USD","LU1992135472.HKD","BK4551","LU2433249047.HKD","BK4528"],"gpt_icon":0},{"id":"2518743770","title":"Is Palo Alto Networks (PANW) the Best Cybersecurity Stock to Buy According to Billionaires?","url":"https://stock-news.laohu8.com/highlight/detail?id=2518743770","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518743770?lang=en_us&edition=fundamental","pubTime":"2025-03-11 19:58","pubTimestamp":1741694337,"startTime":"0","endTime":"0","summary":"We recently published a list of 13 Best Cybersecurity Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Palo Alto Networks, Inc.  stands against other best cybersecurity stocks to buy according to billionaires.The cybersecurity market is poised for significant growth over the coming years, driven by an increasingly complex threat landscape and rapid digital transformation across industries. According to a recent study by Grand View Research Inc., the global cybersecurity market is projected to grow at a compound annual growth rate  of 12.9% from 2025 to 2030. This robust growth is fueled by escalating cyber threats and advanced malware attacks across multiple verticals, including banking, retail, information technology, defense, and manufacturing.In 2024 and into 2025, investments in cyber security are also surging. The Reuters report has highlighted that $4 billion was raised in 2024 by Israeli cybersecurity firms. This underscores that clo","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/palo-alto-networks-panw-best-115857790.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BMPRXN33.USD","IE00B19Z8X17.USD","LU2125909916.SGD","QLD","NVIW.SI","LU2286300806.USD","BK4097","TSYW.SI","IE00BMPRXR70.SGD","LU1861220033.SGD","LU1917777945.USD","BK4560","PANW","LU1548497426.USD","BK4585","BK4550","LU0348723411.USD","QID","LU1169589451.USD","LU1169590202.USD","LU1923622291.USD","IE00B19Z8W00.USD","BK4159","LU2023250843.SGD","TQQQ","CAGR","USAW.SI",".IXIC","LU2265009873.SGD","BK4581","LU2106854487.HKD","PSQ","USJW.SI","BK4588","LU1720051017.SGD","LU2357305700.SGD","IE00B19Z9505.USD","BK4598","LU0234570918.USD","LU1720051108.HKD","SQQQ","LU1989764664.SGD","NQmain","MNQmain","LU1989764748.USD","SG9999001424.SGD","LU1804176565.USD","LU1974910355.USD","BK4532"],"gpt_icon":1},{"id":"2518610748","title":"Biogen announces initiation of dosing in TRANSCEND","url":"https://stock-news.laohu8.com/highlight/detail?id=2518610748","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518610748?lang=en_us&edition=fundamental","pubTime":"2025-03-11 19:40","pubTimestamp":1741693247,"startTime":"0","endTime":"0","summary":"Biogen (BIIB) announced the initiation of dosing in the global clinical study, TRANSCEND. The Phase 3 study will evaluate the efficacy and safety o...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biogen-announces-initiation-of-dosing-in-transcend?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biogen-announces-initiation-of-dosing-in-transcend?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B894F039.SGD","BK4139","BK4585","LU0234570918.USD","LU0889565916.HKD","LU0109394709.USD","IE00B19Z9Z06.USD","LU0320765992.SGD","BK4533","BK4532","BK4588","BIIB","IE00B19Z9P08.USD"],"gpt_icon":0},{"id":"2518418748","title":"OS Therapies Schedules United Kingdom’s Medicines and Healthcare products Regulatory Agency's (MHRA) Scientific Advice Meeting in the Third Quarter of 2025 for Review of its OST-HER2 Immunotherapy Candidate for Osteosarcoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2518418748","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518418748?lang=en_us&edition=fundamental","pubTime":"2025-03-11 19:40","pubTimestamp":1741693200,"startTime":"0","endTime":"0","summary":"NEW YORK, March 11, 2025----OS Therapies, Inc. , a clinical-stage biotechnology company advancing immunotherapies and targeted drug conjugates for cancer treatment, today announced that it has scheduled a Scientific Advice Meeting  in the third quarter of 2025 to discuss the Innovative Licensing and Access Pathway  with the United Kingdom’s  Medicines and Healthcare products Regulatory Agency  for OST-HER2, its immunotherapy candidate for the prevention of recurrence of metastases in osteosarcoma. The Company released positive Phase 2b data in January 2025 that demonstrates statistically significant results in the primary endpoint of the study, 12-month event free survival . The meeting with MHRA has been scheduled to position the Company to bring OST-HER2 to market in the UK in 2025.\"Today’s announcement marks the beginning of the regulatory process required to bring our OST-HER2 immunotherapy to market globally,\" stated OS Therapies’ CEO Paul Romness. \"As we prepare for regulatory in","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/os-therapies-schedules-united-kingdom-114000512.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ADC","BK4139","BK4532","SAM","BK4231","BK4233","BK4158","OSTX","BK4211","BK4585","BK4080","BK4097","BK4137","MDCO","BK4148","BK4528","OST","UBCP","HCSG","OS","DC","BK4017","UK","BK4205","BK4588"],"gpt_icon":0},{"id":"2518471057","title":"QUALCOMM (QCOM): One of the Best Cheap Dividend Stocks to Buy Right Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2518471057","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518471057?lang=en_us&edition=fundamental","pubTime":"2025-03-11 19:30","pubTimestamp":1741692635,"startTime":"0","endTime":"0","summary":"We recently published a list of 13 Best Cheap Dividend Stocks To Buy Right Now. In this article, we are going to take a look at where QUALCOMM Incorporated  stands against other best cheap dividend stocks to buy right now.Former professor-turned-investment manager Josef Lakonishok and value investing specialist David Dreman strongly advocated for a patient, long-term approach to investing, believing that steady, disciplined strategies often outperform rapid, high-growth ones. Their research indicated that value investing tends to outperform growth strategies approximately 70% of the time, regardless of a company’s size. After analyzing companies across different market capitalizations, they found that, over long periods, value stocks consistently generated average annual returns slightly above 7%, surpassing the performance of growth stocks.Drawing comparisons to the dot-com bubble of 2000, JP Morgan highlighted that the leading companies of that era traded at forward price-to-earnings","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/qualcomm-qcom-one-best-cheap-113035330.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0942090050.USD","USJW.SI","LU1069344957.HKD","LU1917777945.USD","BK4534","USAW.SI","BK4585","QID","BK4605","TSYW.SI","LU0868494617.USD","SG9999015978.USD","SG9999015952.SGD","IE00BVYPNQ40.USD",".IXIC","BK4141","QCOM","LU1084165304.USD","LU1119994496.HKD","BK4561","BK4573","LU2247934214.USD","BK4579","LU1261432733.SGD","LU1823568750.SGD","NVIW.SI","LU1035775433.USD","PSQ","NQmain","BK4512","LU1974910355.USD","QLD","BK4532","BK4554","SQQQ","LU2023250504.SGD","GB00BDT5M118.USD","BK4612","TQQQ","LU0079474960.USD","MNQmain","BK4588","LU0868494708.USD","BK4575","BK4527","IE00BSNM7G36.USD","LU2106854487.HKD","BK4604","LU0061475181.USD"],"gpt_icon":1},{"id":"2518177597","title":"Biogen Initiates Phase 3 Study of Felzartamab for the Treatment of Late Antibody-Mediated Rejection (AMR) in Kidney Transplant Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2518177597","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518177597?lang=en_us&edition=fundamental","pubTime":"2025-03-11 19:30","pubTimestamp":1741692600,"startTime":"0","endTime":"0","summary":"Global Phase 3 TRANSCEND study will evaluate the efficacy and safety of felzartamab, as compared to placebo, in adults with late AMRAMR is a leading cause of kidney transplant loss, with approximately","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/11/3040447/0/en/Biogen-Initiates-Phase-3-Study-of-Felzartamab-for-the-Treatment-of-Late-Antibody-Mediated-Rejection-AMR-in-Kidney-Transplant-Patients.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","IE00B19Z9P08.USD","LU0889565916.HKD","LU0234570918.USD","BK4139","BK4006","AMR","IE00B894F039.SGD","BIIB","BK4533","BK4585","BK4588","IE00B19Z9Z06.USD","LU0109394709.USD","BK4532"],"gpt_icon":0},{"id":"2518247745","title":"New Strong Buy Stocks for March 11th","url":"https://stock-news.laohu8.com/highlight/detail?id=2518247745","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518247745?lang=en_us&edition=fundamental","pubTime":"2025-03-11 19:20","pubTimestamp":1741692000,"startTime":"0","endTime":"0","summary":"Here are five stocks added to the Zacks Rank #1  List today:. Hanmi Financial Corporation HAFC: This holding company for Hanmi Bank has seen the Zacks Consensus Estimate for its current year earnings increasing 10.6% over the last 60 days.Hanmi Financial Corporation price-consensus-chart | Hanmi Financial Corporation Quote. Alexander's, Inc.ALX: Thisreal estate investment trust has seen the Zacks Consensus Estimate for its current year earnings increasing 15% over the last 60 days.ESCO Technologies Inc.ESE: This engineered filtration and fluid control company has seen the Zacks Consensus Estimate for its current year earnings increasing 18.8% over the last 60 days.ESCO Technologies Inc. price-consensus-chart | ESCO Technologies Inc. Quote. OneWater Marine Inc. price-consensus-chart | OneWater Marine Inc. Quote. Sprouts Farmers Market, Inc.SFM: This natural and organic grocery retail company has seen the Zacks Consensus Estimate for its current year earnings increasing 11.2% over the la","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/strong-buy-stocks-march-11th-112000374.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4113","BK4214","BK4231","BK4080","BK4161","ESE","HAFC","ALX","LU2355687059.USD","BK4211","SFM","ONEW","LU0053671581.USD","BK4532","IE00B19Z6F94.USD","IE0034390439.USD"],"gpt_icon":0}],"pageSize":16,"totalPage":101,"pageCount":19,"totalSize":1601}]}}